Reciprocal Regulation of CD30 Expression on CD4 + T Cells by IL-4 and IFN-γ

Journal of Immunology

Volumn 158, Issue 5, 1997, Pages 2090-2098

  Nakamura, Tetsuo ^a,b,d   Lee, Richard K ^c   Nam, Sang Y ^c   Al Ramadi, Basel K ^a   Koni, Pandelakis A ^a   Bottomly, Kim ^a,b   Podack, Eckhard R ^c   Flavell, Richard A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD30 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; MALE; METABOLISM; MOUSE; PHYSIOLOGY; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD30; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CLONE CELLS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; TH1 CELLS; TH2 CELLS;

EID: 0031091754     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Schwab, U., H. Stein, J. Gerdes, H. Lemke, H. H. Kirchner, M. Schaadt, and V. Diehl. 1982. Production of a monoclonal antibody specific for Hodgkin and Sternherg-Reed cells of Hodgkin's diseases and a subset of normal lymphoid cells. Nature 299:65.
2. Durkop, H., U. Latza, M. Hummel, F. Eitelbach, B. Seed, and H. Stein. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkins disease. Cell 68:421.
3. Bowen, M. A., K. J. Olsen, L. Cheng, D. Avila, and E. R. Podack. 1993. Functional effects of CD30 on a large granular lymphoma cell line, YT. Inhibition of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation. J. Immunol. 151:5896.
4. Alzona, M., H.-M. Jack, R. Fisher, and T. M. Ellis. 1994. CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 153:2861.
5. + T cells. J. Immunol. 154:9.
6. Hamann, D., C. M. U. Hilkens, J. L. Grogan, S. M. A. Lens, M. L. Kapsenberg, M. Yazdanhakhsh, and R. W. v. Lier. 1996. CD30 expression does not discriminate between human Th1- and Th2-type cells. J. Immunol. 156:1387.
7. + T cell clones in human immunodeficiency virus infection. J. Exp. Med. 180:2407.
8. Prete, G. D., E. Maggi, G. Pizzolo, and S. Romagniani. 1995. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol. Today 16:76.
9. + T cells producing Th2-type cytokines. FASEB J. 9:81.
10. Prete, G. D., M. D. Carli, M. M. D'Elios, K. C. Daniel, F. Almerigogna, M. Alderson, C. A. Smith, E. Thomas, and S. Romagnani. 1995. CD30-mediated signaling promotes the development of human helper type 2-like T cells. J. Exp. Med. 182:1655.
11. Bowen, M. A., R. A. Lee, G. Miragliotta, S. Y. Nam, and E. R. Podack. 1996. Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 156:442.
12. Shanebeck, K. D., C. R. Maliszewski, M. K. Kennedy, K. S. Picha, C. A. Smith, R. G. Goodwin, and K. H. Grabstein. 1995. Regulation of murine B cell growth and differentiation by CD30 ligand. Eur. J. Immunol. 25:2147.
13. Amakawa, R., A. Hakem, T. M. Kundig, T. Matsuyama, J. J. L. Simard, E. Timms, A. Wakeham, H. W. Mittruecker, H. Griesser, H. Takimoto, R. Schmits, A. Shahinian, P. S. Ohashi, J. M. Penninger, and T. W. Mak. 1996 Impaired negative .selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 4:551.
14. Mosmann, T., R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffmann. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
15. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
16. Mosmann, T. R., and R. L. Coffmann. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
17. Cher, D. J., and T. R. Mosmann. 1987. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J. Immunol. 138: 3688.
18. Bottomly, K. 1989. Subset of CD4 T cells and B cell activation. Semin. Immunol. 1:21.
19. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341:746.
20. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interlcukin-4 deficient mice. Science 254:707.
21. Kaye, J., S. Porcelli, J. Tite, B. Jones, and C. A. Janeway, Jr. 1983. Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. J. Exp. Med. 158:836.
22. Jones, B. 1983. Evidence that the Thy-1 molecule is the target for T cell mitogenic antibody against brain-associated antigens. Eur. J. Immunol. 13:678.
23. Landais, D., C. Wallzinger, B. N. Beck, A. Staub, D. J. McKean, C. Benoist, and D. Mathis. 1986. Functional sites on Ia molecules: a molecular dissection of A alpha immunogenicity. Cell 47:173.
24. Kamogawa, Y., L.-a. E. Minasi, S. R. Carding, K. Bottomly, and R. A. Flavell. 1993. The relationship of IL-4- and IFNγ-producing T cells studied by lineage ablation of IL-4 producing cells. Cell 75:985.
25. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
26. Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immonol. Methods 165:37.
27. Wake, C. T., E. O. Long, M. Strubin, N. Gross, R. Accolla, S. Carrel, and B. Mach. 1982. Isolation of cDNA clones encoding HLA-DR α chains. Proc. Natl. Acad. Sci. USA 79:6979.
28. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
29. + T cell receptor transgenic mice. J. Exp. Med. 176:1091.
30. Paul, W. E., and R. A. Seder, 1994. Lymphocyte responses and cytokines. Cell 76:241.
31. + T cells. J. Exp. Med. 182:1591.
32. + T cells. J. Immunol. 158:1085.
33. Lin, J. X., T. S. Migone, M. Tsang, M. Friedman, J. A. Weatherbee, L. Zhou, A. Yamauchi, E. T. Bloom, J. Mietz, S. John, and W. J. Leonard. 1995. The role of shared receptor motifs and common Stat protein in the generation of cytokine plciotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331.
34. Zurawski, S. M., P. Chomarat, O. Djossou, A. N. J. McKenzie, P. Miossec, J. Banchereau, and G. Zurawski. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 270:13869.
35. Hilton, D. J., J. G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, and T. A. Wilson. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93:497.
36. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4:313.
37. Perez, V. C., J. A. Lederer, A. H. Lichtman, and A. K. Abbas. 1995. Stability of Th1 and Th2 populations. Int. Immunol. 7:869.
38. Szabo, S. J., N. G. Jacobson, A. S. Dighe, U. Gubler, and K. M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665.
39. Mocci, S., and R. L. Coffman. 1995. The induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J. Immunol. 154:3779.
40. Murphy, E., K. Shibuya, N. Hosken, P. Openshaw, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1996. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:901.
41. Kotanides, H., and N. C. Reich. 1993. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262:1265.
42. Renz, H., J. Domenico, and E. W. Gelfand. 1991. TL-4-dependent up-regulation of IL-4 receptor expression in murine T and B cells. J. Immunol. 146:3049.
43. Ohara, J., and W. E. Paul. 1988. Up-regulation of interleukin 4/B-cell stimulatory factor I receptor expression. Proc. Natl. Acad. Sci. USA 85:8221.
44. Dokter, W. H. A., P. Borger, D. Hendriks, I. v. d. Horst, M. R. Halie, and E. Vellenga. 1992. Interleukin-4 (IL-4) receptor expression on human T cells is affected by different intracellular signaling pathways and by IL-4 at transcriptional and posttranscriptional level. Blood 80:2721.
45. Zola, H., L. Flego, and H. Weedon. 1993. Expression of IL-4 receptor on human T and B lymphocytes. Cell. Immunol. 150:149.
46. Bach, E. A., S. J. Szabo, A. S. Dighe, A. Ashkenazi, M. Aguet, K. M. Murphy, and R. D. Schreiber. 1995. Ligand-induced autoregulation of IFN-γ receptor β chain expression in T helper cell subsets. Science 270:1215.